首页> 美国卫生研究院文献>Journal of Cancer >miR-21 Expression in Pregnancy-Associated Breast Cancer: A Possible Marker of Poor Prognosis
【2h】

miR-21 Expression in Pregnancy-Associated Breast Cancer: A Possible Marker of Poor Prognosis

机译:miR-21在妊娠相关乳腺癌中的表达:预后不良的可能标志

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Aims: microRNAs (miRNAs) are a class of small noncoding RNAs that can act as key modulators in tumorigenesis-related genes. Specifically, it has been suggested that miR-21 overexpression plays a role in the development and progression of breast cancer. So far, the role of miRNAs in pregnancy-associated breast cancer (PABC) has not been investigated.>Methods and Results: We evaluated miR-21 expression by quantitative RT-PCR in 35 patients, 25 with PABC and 10 control breast cancer cases not pregnancy-associated with similar clinicopathological features. We then analyzed protein expression for PTEN, BCL2 and PDCD4 as miR-21 target genes by IHC, and finally correlated the results with patients' clinicopathological features.Significant overexpression of miR-21 in PABC tumors compared to normal adjacent tissue was found. Overexpression of miR-21 was frequently found in high grade tumors with loss of hormone receptor expression and was significantly associated with positive lymph nodes (p=0.025). In PABC patients, PTEN, BCL2 and PDCD4 target protein expression was decreased in 80%, 76% and 40% respectively.>Conclusion: Our study supports the involvement of miR-21 in breast cancer progression and metastasis formation in PABC implying a role of this miRNA as a marker for poor prognosis in PABC patients.
机译:>目的:microRNA(miRNA)是一类小的非编码RNA,可以作为肿瘤发生相关基因中的关键调节剂。具体而言,已经提出miR-21过表达在乳腺癌的发生和发展中起作用。到目前为止,尚未研究miRNA在妊娠相关乳腺癌(PABC)中的作用。>方法和结果:我们通过定量RT-PCR评估了35例PABC中25例患者的miR-21表达。和10例与妊娠没有临床症状相似的对照乳腺癌病例。然后,我们通过IHC分析了作为miR-21靶基因的PTEN,BCL2和PDCD4的蛋白表达,并最终将结果与患者的临床病理特征相关联。发现与正常相邻组织相比,miR-21在PABC肿瘤中有明显的过表达。 miR-21的过表达常在高级别肿瘤中伴随激素受体表达的丧失而出现,并且与阳性淋巴结显着相关(p = 0.025)。在PABC患者中,PTEN,BCL2和PDCD4目标蛋白表达分别降低了80%,76%和40%。>结论:我们的研究支持miR-21参与乳腺癌的进展和转移形成在PABC中的这种表达暗示该miRNA作为PABC患者预后不良的标志物的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号